Cooperative Agreement for the Provider’s Clinical Support System – Medication Assisted Treatment Supplement

Short Title: PCSS-MAT Supplement
Initial Announcement Back to the Grants Dashboard

Notice of Funding Opportunity (NOFO)

NOFO Number: TI-17-003

Posted on Grants.gov: Tuesday, December 27, 2016

Application Due Date: Friday, March 03, 2017

Catalog of Federal Domestic Assistance (CFDA) Number: 93.243

Intergovernmental Review (E.O. 12372): Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.

Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.

Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) announces the availability of two-year supplemental funding to enable the grantee from the Fiscal Year (FY) 2016 Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment (PCCS-MAT) cohort to expand/enhance grant activities required under the FY 2016 Funding Opportunity Announcement (FOA). Information on this program may be found in the original funding announcement, TI-16-003 available on the SAMHSA website at http://www.samhsa.gov/grants/grant-announcements/ti-16-003.

The Cooperative Agreement for the Provider’s Clinical Support System – Medication Assisted Treatment Supplement (Short Title: PCSS-MAT Supplement) program purpose is to expand on the Drug Addiction Treatment Act (DATA) of 2000 and continue SAMHSA’s currently funded PCSS-MAT initiative. The current PCSS-MAT initiative has provided 267 wavier trainings, 88 online continuing medical educational/clinical educational (CME/CE) courses, a no cost clinical coaching/mentoring support for all health professionals in primary care, and has trained over 32,000 health professionals. The PCSS-MAT program has provided up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of substance use disorders, addiction, and co-occurring mental disorders. This supplement will provide additional support to the current PCSS-MAT grantee by enhancing/expanding medication assisted treatment (MAT) training and educational resources to health professionals on evidence-based practices for preventing, identifying, and treating opioid use disorders. Grant funds received under this supplement may only be used to support new activities and to serve new populations. PCSS-MAT Supplement funds need to be tracked separately from original grant (TI-16-003) funds.

Eligibility

Eligibility is limited to the current SAMHSA FY 2016 PCCS-MAT grantee, the American Academy of Addiction Psychiatry. Eligibility is limited because this is the most effective way to accomplish the goals of this two-year supplement since the current grantee has the necessary knowledge, experience, and key partnerships in place to carry out grant activities without a lengthy start-up period.

Award Information

Funding Mechanism: Cooperative Agreement

Anticipated Total Available Funding: $1 million

Anticipated Number of Awards: One (1) award

Anticipated Award Amount: Up to $1 million

Length of Project: Up to two (2) years

Cost Sharing/Match Required?: No

Proposed budgets cannot exceed the allowable amount in any year of the supplement. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Funding estimates for this announcement are based on an annualized Continuing Resolution and do not reflect the final FY 2017 appropriation. Applicants should be aware that funding amounts are subject to the availability of funds.

Contact Information

Last Updated: